Fitness Trends Non-Invasive Cancer Diagnostics Market | Page 3

• Research Findings and Conclusion
Non-Invasive Cancer Diagnostics Market - Regional Analysis
On the basis of region, the global non-invasive cancer diagnostics market is segmented into
North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America
holds a dominant position in the non-invasive diagnostics market, owing to increasing incidence
of cancer, increasing technological advancement, better reimbursement scenario, and
governmental initiatives for screening of cancer in early stages. For instance, the American
Cancer Society Guidelines for the early detection of cancer offers various screening plans at
different ages. For example, the guidelines suggest that women between the age of 40 and 44
must screen for breast cancer annually.
Request For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/1651
Non-Invasive Cancer Diagnostics Market – Competitive Landscape
Some of the key players operating in the global non-invasive cancer diagnostics market include
Roche Diagnostics, Hologic Inc., Qiagen, Gen-Probe Inc., Digene Corporation, Abbott Molecular,
IVDiagnostics, Laboratory Corporation of America Holdings, OncoCyte Corporation, Arquer
Diagnostics Ltd. and Affymetrix Inc.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: [phone]
Email: [e-mail]